(Q53676885)

17 May 2018

review article

1 reference

title

The pathophysiology of acute graft-versus-host disease. (English)

1 reference

17 May 2018

1 reference

2

1 reference

17 May 2018

author name string

Jaksch M

series ordinal

1

1 reference

17 May 2018

publication date

1 May 2005

1 reference

17 May 2018

Scandinavian Journal of Immunology

published in

1 reference

17 May 2018

volume

61

1 reference

17 May 2018

issue

5

1 reference

17 May 2018

page(s)

398-409

1 reference

17 May 2018

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytokine dysregulation as a mechanism of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Can graft endothelial cells initiate a host anti-graft immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Immunosuppressive strategies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Challenges to achieving clinical transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

The role of T-cell costimulatory activation pathways in transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Transcription: tantalizing times for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Interferon gamma is required for activation-induced death of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cellular therapy: exploiting NK cell alloreactivity in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Control of T-cell activation by CD4+ CD25+ suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Inhibition of graft-versus-host disease by double-negative regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

21 January 2018

The CTL's kiss of death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Biologically relevant metal ion-dependent hydroxyl radical generation. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

How do cytotoxic lymphocytes kill their targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01595.X

10.1111/J.1365-3083.2005.01595.X

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018